# Concurent Chemoradiotherapy in Head and Neck Cancers

> **NCT04780750** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT04780750
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780750, "Concurent Chemoradiotherapy in Head and Neck Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04780750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*